Price, Martin J.; Briggs, Andrew H. - In: PharmacoEconomics 20 (2002) 3, pp. 183-194
Background and objective: Asthma is a chronic-episodic disease characterised by acute, symptomatic episodes of varying severity. We developed a Markov model that can be used to estimate the cost effectiveness of alternative asthma treatments. Because of the costs they incur, asthma exacerbations...